PNC Financial Services Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,500
Closed -$45K 4888
2022
Q3
$45K Hold
2,500
﹤0.01% 3034
2022
Q2
$31K Hold
2,500
﹤0.01% 3282
2022
Q1
$33K Hold
2,500
﹤0.01% 3337
2021
Q4
$39K Hold
2,500
﹤0.01% 3249
2021
Q3
$56K Hold
2,500
﹤0.01% 3002
2021
Q2
$57K Hold
2,500
﹤0.01% 2992
2021
Q1
$51K Hold
2,500
﹤0.01% 2976
2020
Q4
$69K Sell
2,500
-100
-4% -$1.95K ﹤0.01% 2713
2020
Q3
$37K Sell
2,600
-61
-2% -$1.14K ﹤0.01% 2898
2020
Q2
$55K Buy
2,661
+2,500
+1,553% +$34K ﹤0.01% 2716
2020
Q1
$1K Buy
161
+61
+61% +$684 ﹤0.01% 3847
2019
Q4
$2K Buy
+100
New +$1.01K ﹤0.01% 3824
2018
Q3
Sell
-1,750
Closed -$40K 4282
2018
Q2
$40K Hold
1,750
﹤0.01% 3138
2018
Q1
$37K Hold
1,750
﹤0.01% 3139
2017
Q4
$22K Hold
1,750
﹤0.01% 3370
2017
Q3
$27K Hold
1,750
﹤0.01% 3231
2017
Q2
$20K Hold
1,750
﹤0.01% 3332
2017
Q1
$21K Hold
1,750
﹤0.01% 3280
2016
Q4
$22K Buy
+1,750
New +$20.3K ﹤0.01% 3204

Other funds holding MYOV

PNC Financial Services Group's MYOV Position: Q4 2022 in Review

PNC Financial Services Group sold out of Myovant Sciences Ltd. (MYOV) in Q4 2022, closing a stake of 2,500 shares — an estimated $45K sold.

PNC Financial Services Group first reported a position in MYOV in Q4 2016 and held it in 19 quarters. The position peaked at $69K in Q4 2020. 118 funds tracked by Wall St. Rank hold MYOV as of Q4 2022.

  • PNC Financial Services Group reported no remaining Myovant Sciences Ltd. position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 2,500 Myovant Sciences Ltd. shares in Q4 2022, an estimated $45K.
  • PNC Financial Services Group first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 19 quarters.
  • PNC Financial Services Group's Myovant Sciences Ltd. position peaked at $69K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.